๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

PCV60 ECONOMIC ANALYSIS OF ENDEAVOR VS. CYPHER STENTS: RESULTS FROM THE ENDEAVOR III TRIAL

โœ Scribed by EL Eisenstein; MB Leon; DE Kandzari; R Edwards; PA Cowper; DF Kong; MD Silverstein; DB Mark; KJ Anstrom

Book ID
118611421
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
90 KB
Volume
12
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Long-Term Clinical and Economic Analysis
Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent: 4-Year Results From the ENDEAVOR II Trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions)
โœ Eric L. Eisenstein; William Wijns; Jean Fajadet; Laura Mauri; Rex Edwards; Patri ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› American College of Cardiology ๐ŸŒ English โš– 364 KB
Late-Term Clinical Outcomes With Zotarol
Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)
โœ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› American College of Cardiology ๐ŸŒ English โš– 704 KB